ADHERENCE TO SECONDARY PREVENTION MEDICINES BY CORONARY ARTERY DISEASE PATIENTS -EXPLORING BARRIERS TO INFORM INTERVENTIONS  by Khatib, Rani & Hall, Alistair
Chronic CAD/Stable Ischemic Heart Disease
E1460
JACC March 27, 2012
Volume 59, Issue 13
ADHERENCE TO SECONDARY PREVENTION MEDICINES BY CORONARY ARTERY DISEASE PATIENTS - 
EXPLORING BARRIERS TO INFORM INTERVENTIONS
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Monday, March 26, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Nuances and New Insights
Abstract Category: 3. Chronic CAD/Stable Ischemic Heart Disease: Therapy
Presentation Number: 1210-541
Authors: Rani Khatib, Alistair Hall, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, University of Leeds, Leeds, United Kingdom
Background: Non-adherence (NA) to secondary prevention medicines (SPM) for coronary artery disease (CAD) has major health and cost 
implications to patients & healthcare systems. Interventions to improve adherence should be individualized. We explored self-reported NA to SPM in 
our patients to inform the development of suitable interventions.
Methods: A postal survey explored NA behavior using the Morisky Medicines Adherence 8 items scale, Single Question Scale, Beliefs about 
Medicines & practical barriers to adherence (e.g. ordering repeat prescriptions). A purposive sample of 696 patients with established CAD and on 
any SPM for at least 3 months was surveyed. Ethical approval was granted.
Results: 500 patients completed all sections of the questionnaire. Levels of NA to at least one SPM was 44%. See table 1.
Conclusions: Contrary to common practice which assumes interventions should be targeted at older patients, our findings show that younger 
male patients were more likely to be non-adherent in our population. Our interventions need to alleviate specific concerns about SPM, address 
problems with ordering repeat prescriptions, and target medicines-taking behavior issues around aspirin. We conclude that rather than depending 
on extrapolations from the literature when developing interventions to address NA, healthcare professionals need to examine specific modifiable 
barriers to adherence in their population in order to individualize interventions. This is more likely to improve adherence.
Table 1. Multivariate Logistic Regression Analysis - Odds Ratio for NA (p-values <0.05)
Variable OR 95% CI
Age (years) 0.96 0.94, 0.98
Gender (Male - Female) 0.53 0.32, 0.89
Specific Concern about SPM (average) 1.91 1.50, 2.43
Issues with Repeat Prescriptions 2.50 1.26, 4.94
Aspirin (prescribed) 2.18 1.15, 4.12
